期刊
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
卷 33, 期 1, 页码 3-7出版社
SPRINGER INDIA
DOI: 10.1007/s12288-017-0777-0
关键词
Multiple myeloma; Biology; Novel drugs; Autologous transplants
类别
The plasma cell disorders constitute a heterogeneous group of diseases. Accumulation of knowledge in the field has helped us to understand these diseases better, stage them more precisely, prognosticate more accurately and manage them more effectively. The paradigm shift in the management of multiple myeloma over the last one-and-a-half decades shows no signs of slackening. In addition to novel therapies, better supportive care and high-dose melphalan with autologous hematopoietic stem cells have contributed to this positive outcome. This review summarizes the developments in this sphere in the recent past.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据